Last Updated on October 17, 2024 by The Health Master
Mumbai: Lupin Limited announced that it has received approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Meclizine Hydrochloride Tablets USP.
The Meclizine Hydrochloride Tablets, 12.5 mg, 25 mg, and 50 mg, to market a generic equivalent of Antivert Tablets, 12.5 mg, 25 mg, and 50 mg, of Casper Pharma LLC, will be manufactured at Lupin’s facility in Goa.
Meclizine Hydrochloride Tablets (RLD Antivert) had an estimated annual sales of USD 29 million in the US.
USFDA gives nod for Prochlorperazine Maleate Tablets
USFDA gives approval generic Labetalol HCL tablets
USFDA gives final approval for Adapalene and Benzoyl Peroxide Topical Gel
USFDA gives final approval for Empagliflozin tablets
USFDA gives final approval to market this anti-inflammatory skin cream
USFDA grants approval for generic Cyclosporine Soft Gel capsules
Johnson & Johnson to end global sales of talc-based baby powder
USFDA gives nod for Prochlorperazine Maleate Tablets
Possible carcinogen found in some Diabetes drugs: USFDA
USFDA issues Form 483 for 4 observations to Zydus
DCGI notifies classification of 60 Medical Devices related to rehabilitation
Govt reconstitutes National Medical Devices Promotion Council
IPC releases revised draft general chapters on microbiology in IP
USFDA gives approval generic Labetalol HCL tablets
USFDA completes inspection at Stride Pharma with zero observation
Latest Notifications regarding Pharmaceuticals
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
